The invention provides a pharmaceutical agent delivery composition comprising: (i) a transport polymer comprising a linear or branched peptide having from about 10 to about 300 amino acid residues, having from about 5 to 100% histidine residues, and optionally having from 0 to about 95% non-histidine amino acid residues; (ii) at least one pharmaceutical agent; and optionally (iii) one or more intracellular delivery components in association with the transport polymer. The invention also provides methods for using such composition to deliver the pharmaceutical agent to the interior of cells.
本发明提供了一种药剂递送组合物,该组合物包括:(i) 由线性或支链
多肽组成的转运聚合物,该
多肽具有约 10 至约 300 个
氨基酸残基,组
氨酸残基含量约为 5 至 100%,非组
氨酸
氨基酸残基含量可选为 0 至约 95%;(ii) 至少一种药剂;以及可选的(iii) 一种或多种与转运聚合物结合的细胞内递送组分。本发明还提供了使用这种组合物向细胞内部递送药剂的方法。